Publications
- A phase 1 study of pemetrexed (ALIMTA) and cyclophosphamide in patients with locally advanced or metastatic breast cancer2006 | First Faculty of Medicine
- A phase 1 study of pemetrexed (ALIMTA) and cyclophosphamide in patients with locally advanced or metastatic breast cancer2006 | Faculty of Physical Education and Sport
- Pemetrexed and cyclophospadmide in patients with locally advaced or metastatic breast cancer: A phase I study2003 | First Faculty of Medicine
- Efficacy of weekly transtuzumab and paclitaxel in the treatment of women with HER-2/neu overexpressing metastatic breast cancer. The impact of taxane free interval on treatment outcomes2002 | First Faculty of Medicine
- Phase I study of pemetrexed (ALIMTA) and cyclophosphamide inpatients with locally advanced or metastatic breast cancerPublication without faculty affiliation
- Weekly trastuzumab (T) and paclitaxel (P) in metastatic breast cancer (MBC). The impact of taxane free interval (TFI) on treatment outcomePublication without faculty affiliation
- Tyrosinkinázové inhibitory EGFR, ALK a HER2 u pokročilého nemalobuněčného karcinomu plic2016 | First Faculty of Medicine
- Testing for oncogenic molecular aberrations in cell-free DNA-based liquid biopsies in the clinic: are we there yet?2015 | Faculty of Medicine in Pilsen
- Novel therapeutic targets in non-small cell lung cancer2011 | First Faculty of Medicine
- Novel therapeutic targets in non-small cell lung cancer.2011 | First Faculty of Medicine
Loading network view...